Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
3.232
-0.098 (-2.95%)
Jul 16, 2025, 11:05 AM - Market open
Inventiva Employees
As of December 31, 2024, Inventiva had 118 total employees, including 114 full-time and 4 part-time employees. The number of employees decreased by 5 or -4.07% compared to the previous year.
Employees
118
Change (1Y)
-5
Growth (1Y)
-4.07%
Revenue / Employee
$123,657
Profits / Employee
-$1,616,232
Market Cap
445.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IVA News
- 6 days ago - Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance - GlobeNewsWire
- 8 days ago - Inventiva receives $10 million milestone payment from CTTQ - GlobeNewsWire
- 13 days ago - Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease - GlobeNewsWire
- 7 weeks ago - Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference - GlobeNewsWire
- 7 weeks ago - Inventiva reports 2025 First Quarter Financial Information¹ - GlobeNewsWire
- 7 weeks ago - Results of the Votes of the Combined Shareholders' General Meeting of May 22, 2025 - GlobeNewsWire
- 2 months ago - Inventiva secures the €116 million second tranche of its structured financing of up to €348 million - GlobeNewsWire
- 2 months ago - Combined General Meeting of May 22, 2025 - Availability of the preparatory documents - GlobeNewsWire